Pierre Thibault and Mike Tyers, winners of Genome Canada’s Genomics Technology Platforms 2016 Competition

The IRIC is proud to announce that it has been granted a funding of 3.41 M$ for its Centre for Advanced Proteomic and Chemogenomic Analyses (CAPCA), led by Pierre Thibault and Mike Tyers, both Principal Investigators at the IRIC, as part of Genome Canada’s “Genomics Technology Platforms 2016 Competition for Operations Support and Technology Development […]

The sweet tooth of melanoma explained

by Martin Primeau When they become cancerous, cells accelerate their metabolism to become real “sugar addicts”. This behavioral change provides them with a lot of energy, enough to accelerate their growth and multiplication. But how do they manage to change their eating habits? This is what Professor Philippe Roux’s team from the IRIC wanted to […]

The intimate bond between three proteins linked to cancer now unveiled

By Martin Primeau The team of Marc Therrien, Scientific Director and Principal Investigator at the IRIC, proposes a true paradigm shift in an article just published in the prestigious scientific journal Nature. Professor Therrien’s group was interested in the mechanism of activation of BRAF, a protein involved in many cancers because of its role as […]

In vivo science and artificial intelligence join forces to advance tools in cancer treatment and management

Montreal, February 8, 2018 — It will become easier to discover imaging biomarkers and identify digital surrogates for modern end-points in personalized therapies, thanks to a partnership between Sylvain Meloche – Principal Investigator within the signaling and cell growth research unit at the Institute for Research in Immunology and Cancer (IRIC) – along with his […]

Women & Science

On Sunday February 11th, the IRIC will be present at the Science Center for the Women & Science Forum. Three IRIC investigators will take part in the event by presenting their work to encourage young girls’ interest in science. Julie Lessard (Chromatin Structure and Stem Cell Biology), Delphine Bouilly (Design and Application of Electronic Nanobiensensors) and Trang Hoang […]

Cancer: Hopes and Challenges

On February 1st, the IRIC held the breakfast Cancer: hopes and challenges for the occasion of World Cancer Day (February 4th), hosted by Yanick Villedieu. Four IRIC Investigators spoke about cancer research in 2018 while highlighting its importance in the fight against the disease – the first cause of death in Canada, according to the Canadian Cancer Society. Around 100 […]

Genetic analysis of essential human genes, Mike Tyers and his team published in Molecular and Cellular Biology

The human genome contains about 20,000 genes that encode the proteins that specify the structure and function of all tissues and organs in the body. Essential proteins are central to the structure of cells and tend to be mutated more frequently in disease. The understanding of these essential functions is critical to deciphering cancer and […]

In memoriam: Dr. Jacques Genest Sr.

It is with profound sadness that we learn the loss of Dr. Jacques Genest Sr. on January 5th, 2018. Our institute wishes to extend its sincere condolences to Dr. Genest’s family, the IRCM, and the entirety of the life sciences community. Dr. Genest was, without a doubt, a unique visionary who contributed to the development […]

Two IRIC Principal Investigators receive a new Canada Research Chair

Delphine Bouilly and Matthew J. Smith, Principal Investigators at the IRIC, both received a new Canada Research Chair of the October 2016 competition. The federal program allows to recruit and retain the best researchers. Leading the Design and Application of Electronic Nanobiosensors Research Unit, Delphine Bouilly is the most recent and youngest IRIC recruit. Trained […]

Better understanding GPCRs: Michel Bouvier and his team publish in Nature Communications

Today, Michel Bouvier, the IRIC’s CEO, and his team, publish an article in Nature Communications. In other words, Professor Bouvier’s team identified the specific domains within the receptor that are responsible for activating specific signalling pathways, which explains how different drugs binding to the b2-adrenergic receptor can activate distinct signalling pathways. The discovery opens the […]

Next Page »

Follow IRIC

Logo UdeM